BRIEF published on 10/04/2024 at 12:04, 1 month 18 days ago Societe Generale Increases Stake in Britvic PLC Voting Rights Société Générale Britvic Plc Investment Financial Notification
PRESS RELEASE published on 10/04/2024 at 11:59, 1 month 18 days ago Holding(s) in Company Societe Generale notified an acquisition of voting rights in Britvic plc. The total voting rights held by Societe Generale is 5.46% as of 03-Oct-2024 Acquisition Voting Rights Société Générale Britvic Plc Notification
BRIEF published on 10/04/2024 at 08:49, 1 month 18 days ago Morgan Stanley Increases Stake in Britvic PLC Voting Rights Britvic Plc Shareholding Morgan Stanley Equity Swaps
PRESS RELEASE published on 10/04/2024 at 08:44, 1 month 18 days ago Holding(s) in Company Morgan Stanley discloses acquisition of voting rights in Britvic PLC to reach 5.132% through direct and financial instruments. Notification made on 01-Oct-2024 Acquisition Voting Rights Britvic Plc Notification Morgan Stanley
BRIEF published on 10/03/2024 at 15:45, 1 month 18 days ago Major Holding Change in Britvic PLC Voting Rights Société Générale Shareholding Britvic Regulatory Update
PRESS RELEASE published on 10/03/2024 at 15:40, 1 month 18 days ago Holding(s) in Company Societe Generale crosses 4.249% threshold in Britvic plc (BVIC) on 02-Oct-2024. Notification made on 03-Oct-2024 Voting Rights Société Générale Major Holdings Notification Britvic Plc BVIC
BRIEF published on 10/03/2024 at 14:59, 1 month 18 days ago Vanguard Group's Investment Position in Britvic plc Securities Disclosure Investment Vanguard Britvic
PRESS RELEASE published on 10/03/2024 at 14:54, 1 month 18 days ago Form 8.3 - The Vanguard Group, Inc.: Britvic plc The Vanguard Group, Inc. discloses 5.44% ownership in Britvic plc. Purchase of 20p ordinary shares at 12.76 GBP and 12.77 GBP per unit on 02 Oct 2024 The Vanguard Group, Inc. Britvic Plc Ownership Disclosure Purchase 20p Ordinary Shares
BRIEF published on 10/03/2024 at 12:39, 1 month 18 days ago Morgan Stanley Increases Stake in Britvic plc Voting Rights Britvic Plc Shareholding Morgan Stanley Financial Instruments
PRESS RELEASE published on 10/03/2024 at 12:34, 1 month 18 days ago Holding(s) in Company Morgan Stanley notified an acquisition of voting rights in Britvic plc (BVIC) on 30-Sep-2024, reaching a total of 5.02% voting rights Acquisition Voting Rights Britvic Plc BVIC Morgan Stanley
Published on 11/22/2024 at 09:00, 3 hours 23 minutes ago Industrial Software Company mlean Celebrates 10 Years of Continuous Improvement
Published on 11/22/2024 at 00:00, 12 hours 23 minutes ago Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 14 hours 18 minutes ago Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 14 hours 33 minutes ago Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 16 hours 8 minutes ago Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/22/2024 at 11:54, 29 minutes ago PIERER Mobility denies media reports about Mark Mateschitz's participation in PIERER Mobility and KTM
Published on 11/22/2024 at 11:45, 38 minutes ago How 5G Transforms Life: A Foreigner's Journey Through East China's Digital Revolution
Published on 11/22/2024 at 11:21, 1 hour 2 minutes ago Original-Research: ParTec AG (von First Berlin Equity Research GmbH): Buy
Published on 11/22/2024 at 11:06, 1 hour 17 minutes ago Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 06:58, 1 day 5 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 17 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 18 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 18 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 2 days 4 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
